We performed immunofluorescence-based histo-cytometry of CD163+ TAMs on tissue microarrays representing a retrospective cohort of 443 cases of invasive breast cancer from patients who subsequently received adjuvant chemotherapy. The gene discussed is CD163; the disease is invasive breast carcinoma.